Corbus Pharmaceuticals Holdings, Inc.·4

Nov 16, 4:09 PM ET

Tepper Mark 4

4 · Corbus Pharmaceuticals Holdings, Inc. · Filed Nov 16, 2018

Insider Transaction Report

Form 4
Period: 2018-11-14
Tepper Mark
President and CSO
Transactions
  • Exercise/Conversion

    Common Stock

    2018-11-14$1.00/sh+10,000$10,0002,110,400 total
  • Exercise/Conversion

    Option to purchase common stock

    2018-11-1410,000261,600 total
    Exercise: $1.00From: 2015-04-11Exp: 2024-04-11Common Stock (10,000 underlying)

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION